|
|
Time |
Source |
|
Announcement
|
|
| 02 Feb 2021 |
11:17 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
CORRECTING and REPLACING -- Verona Pharma Reports Positive Phase 2 Results with pMDI Formulation of Ensifentrine in COPD |
| 14 Jan 2021 |
7:00 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma Completes Enrollment in Pilot Study of pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19 |
| 05 Jan 2021 |
7:00 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma to Present at H.C. Wainwright Virtual BioConnect Conference |
| 23 Nov 2020 |
7:00 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma Secures up to $30 Million Debt Financing from Silicon Valley Bank |
| 09 Nov 2020 |
7:00 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma Announces November 2020 Virtual Investor Conference Participation |
| 30 Oct 2020 |
7:00 am |
RNS
|
|
|
AIM |
Cancellation - Verona Pharma PLC |
| 29 Oct 2020 |
7:00 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma plc Operational Update and Financial Results for the Three and Nine Months Ended September 30, 2020 |
| 28 Oct 2020 |
11:01 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma plc : Update on AIM Delisting |
| 23 Oct 2020 |
5:30 pm |
RNS
|
|
|
FTSE Russell |
Verona Pharma |
| 22 Oct 2020 |
7:00 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma to Announce Interim Results for the Three and Nine Months Ended September 30, 2020 and Provide Corporate Update |
| 13 Oct 2020 |
7:00 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma to Present Phase 2b COPD Symptom and Quality of Life Data with Ensifentrine at CHEST 2020 |
| 23 Sep 2020 |
9:06 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma Initiates Phase 3 Clinical Trials with Nebulized Ensifentrine for the Maintenance Treatment of COPD |
| 21 Sep 2020 |
7:00 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Intended Delisting and Cancellation of Ordinary Shares from Trading on AIM |
| 17 Sep 2020 |
7:00 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma to Ring the Nasdaq Closing Bell to celebrate $200 million financing |
| 16 Sep 2020 |
1:25 pm |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma Announces Publication of Phase 2b COPD Symptom Data in the International Journal of Chronic Obstructive Pulmonary Disease |
| 08 Sep 2020 |
7:00 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma Initiates Pilot Study with pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19 |
| 02 Sep 2020 |
7:00 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma to Present at H.C. Wainwright 22nd Annual Global Virtual Investment Conference |
| 26 Aug 2020 |
10:19 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma plc: Grant of RADSUs and PDMR Dealings |
| 24 Aug 2020 |
7:00 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma to Present Phase 2b data with Ensifentrine in COPD at the European Respiratory Society International Congress 2020 |
| 19 Aug 2020 |
7:00 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma Initiates Multiple Dose Part of Phase 2 Clinical Trial with pMDI Formulation of Ensifentrine in COPD |
| 14 Aug 2020 |
11:05 am |
RNS
|
|
|
Verona Pharma PLC (VRP) |
Second Price Monitoring Extn |
| |
11:00 am |
RNS
|
|
|
Verona Pharma PLC (VRP) |
Price Monitoring Extension |
| |
7:00 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma plc Operational Update and Financial Results for the Three and Six Months Ended June 30, 2020 |
| 07 Aug 2020 |
3:46 pm |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma plc: TR-1: Standard form for notification of major holdings |
| 04 Aug 2020 |
6:13 pm |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma plc: Issue of Equity, PDMR Dealings & Total Voting Rights |
| 03 Aug 2020 |
7:00 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma Announces August 2020 Virtual Investor Conference Participation |
| 30 Jul 2020 |
10:52 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma plc: TR-1: Standard form for notification of major holdings |
| |
7:00 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma to Announce Interim Results for the Three and Six Months Ended June 30, 2020 and Provide Corporate Update |
| 27 Jul 2020 |
7:01 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma plc: TR-1: Standard form for notification of major holdings |
| 22 Jul 2020 |
4:50 pm |
GNW
|
|
|
Verona Pharma plc (VRP) |
Closing of Financing, Issued Share Capital and Total Voting Rights |
| 17 Jul 2020 |
5:47 pm |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma plc: PDMR Dealings |
| |
7:00 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma Raises $200 Million in Oversubscribed Private Placement and Subscription |
| 06 Jul 2020 |
4:04 pm |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma plc: Issue of Equity and Total Voting Rights |
| 14 May 2020 |
7:00 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma Announces FDA Response to End-of-Phase 2 Briefing Package for Ensifentrine in COPD and Outlines Phase 3 ENHANCE Clinical Program |
| 12 May 2020 |
1:11 pm |
GNW
|
|
|
Verona Pharma plc (VRP) |
Director/PDMR Shareholding - Grant of Restricted Stock Units, Issue of Equity, Total Voting Rights & PDMR Dealings |
| 01 May 2020 |
5:12 pm |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma Presents Expanded Analysis of Ensifentrine Clinical Data in COPD Maintenance Treatment at the American Thoracic Society 2020 International Conference |
| 30 Apr 2020 |
7:00 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma plc: Operational Update and Financial Results for the Three Months Ended March 31, 2020 |
| 23 Apr 2020 |
7:00 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma to Announce Financial Results for the Three Months Ended March 31, 2020 and Provide Corporate Update |
| 16 Apr 2020 |
12:12 pm |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma plc: Results of AGM |
| 08 Apr 2020 |
7:00 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Update on AGM Procedure |
| 31 Mar 2020 |
7:00 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma Reports Positive Efficacy and Safety Data with Single Dose pMDI Formulation of Ensifentrine in COPD |
| 20 Mar 2020 |
11:28 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma plc: Issue of Equity and Total Voting Rights |
| 17 Mar 2020 |
2:06 pm |
RNS
|
|
|
Verona Pharma PLC (VRP) |
Second Price Monitoring Extn |
| |
2:01 pm |
RNS
|
|
|
Verona Pharma PLC (VRP) |
Price Monitoring Extension |
| 16 Mar 2020 |
5:13 pm |
GNW
|
|
|
Verona Pharma plc (VRP) |
2019 Annual Report and Accounts and Notice of AGM |
| 05 Mar 2020 |
4:01 pm |
GNW
|
|
|
Verona Pharma plc (VRP) |
Grant of Restricted Stock Units and PDMR Dealings |
| 27 Feb 2020 |
7:00 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma Reports Financial Results for the Full Year Ended December 31, 2019 and Provides Corporate Update |
| 21 Feb 2020 |
7:00 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma plc to Announce Financial Results for Full Year Ended December 31, 2019 and Provide Corporate Update |
| 14 Feb 2020 |
7:00 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma Announces Publication of Key Phase 2b COPD Data in Respiratory Research |
| 07 Feb 2020 |
7:00 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Holding(s) in Company TR-1: Standard form for notification of major holdings |
| 28 Jan 2020 |
7:00 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma to Present at LSX World Congress 2020 |
| 17 Jan 2020 |
1:06 pm |
GNW
|
|
|
Verona Pharma plc (VRP) |
Holding(s) in Company TR-1: Standard form for notification of major holdings |
| 13 Jan 2020 |
4:41 pm |
RNS
|
|
|
Verona Pharma PLC (VRP) |
Second Price Monitoring Extn |
| |
4:35 pm |
RNS
|
|
|
Verona Pharma PLC (VRP) |
Price Monitoring Extension |
| |
5:00 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma Reports Positive Top-line Data in 4 Week Phase 2b COPD Study with Nebulized Ensifentrine on Top of Tiotropium Therapy |
| 10 Jan 2020 |
11:00 pm |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma to Report 4 Week Phase 2b COPD Dose-ranging Study Results with Nebulized Ensifentrine on Top of Tiotropium Therapy |
| 07 Jan 2020 |
7:00 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma Appoints David Moskowitz as Vice President, Capital Markets Strategy & Investor Relations |
| 28 Nov 2019 |
10:25 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Holding(s) in Company TR-1: Standard form for notification of major holdings |
| 27 Nov 2019 |
7:00 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma plc: Grant of Options to PDMR |
| 18 Nov 2019 |
7:00 am |
GNW
|
|
|
Verona Pharma plc (VRP) |
Verona Pharma plc: PDMR Dealing – Purchase by Chairman |